HIV TRENDS UNIVERSAL ACCESS TO HIV TREATMENT IN KENYA

Similar documents
Annual Scientific conference of Kenya Association of Physicians

Challenges and Opportunities for Responding to HIV/AIDS in LDCs. Mazuwa Banda Department of HIV/AIDS World Health Organization

Scaling up priority HIV/AIDS interventions in the health sector

ANNEX 5: Estimated Financing Requirements (Continued)

Treat All : From Policy to Action - What will it take?

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)

INNOVATIONS IN VMMC SERVICE DELIVERY IN KENYA

ON THE FAST-TRACK TO ACCELERATE THE FIGHT AGAINST HIV AND TO END THE AIDS EPIDEMIC BY 2030

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Kenya

Strategic Plan Annual Results Briefing

FERTILITY AND FAMILY PLANNING TRENDS IN URBAN KENYA: A RESEARCH BRIEF

REGIONAL COMMITTEE FOR AFRICA AFR/RC54/14 Rev June 2004

IFMSA Policy Statement Ending AIDS by 2030

The Global Fund & UNICEF Partnership

Towards universal access

1.2 Building on the global momentum

Scaling Up Treatment in Zimbabwe: The path to high coverage

ustainable Development Goals

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH

Concept note. 1. Background and rationale

Children and AIDS Fourth Stocktaking Report 2009

REGIONAL COMMITTEE FOR AFRICA AFR/RC53/13 Rev June 2003 Fifty-third session Johannesburg, South Africa, 1 5 September 2003

7.5 South-East Asian Region: summary of planned activities, impact and costs

SCALING UP TOWARDS UNIVERSAL ACCESS

World Health Organization. A Sustainable Health Sector

Partnerships between UNAIDS and the Faith-Based Community

No. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets

DRAFT: Sexual and Reproductive Rights and Health the Post-2015 Development Agenda

Monitoring of the achievement of the health-related Millennium Development Goals

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030

BUDGET AND RESOURCE ALLOCATION MATRIX

Contextual overview with reference to MDG Goal 6 and projection for Post-2015

Economic and Social Council

Program to control HIV/AIDS

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

The road towards universal access

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

DECISION MAKING FOR NCDs IN KENYA. Dr. Francis Kimani Director of Medical Services Ministry of Medical Services, Government of Kenya

DETERMINANTS OF PATHWAYS TO HIV TESTING IN RURAL AND URBAN KENYA: EVIDENCE FROM THE 2008 KENYA DEMOGRAPHIC AND HEALTH SURVEY

A Call to Action Children The missing face of AIDS

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

NAMIBIA INVESTMENT CASE

Action plan for the health sector response to viral hepatitis in the WHO European Region

Making a difference through health How PwC is helping to change lives

Conference Item (paper)

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

Sessional Paper No. 3 of 2012 on Population Policy for National Development

Global call for action to ensure universal access to malaria diagnosis and treatment

Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts)

The Investment Framework

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS

ART for prevention the task ahead

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

Kenya. Service Provision Assessment Survey Family Planning Key Findings

Operational Research on PMTCT Lessons Learned and Gaps

CARE FOR HIV PATIENTS IN RURAL SOUTH AFRICA

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018

Women and ARVs for HIV prevention: what do we need to think about?

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

Aidspan Review of a Study on the Costs and Health Impact of Continued Global Fund Support for Antiretroviral Therapy

guidance for Goal of this chapter 10.1 Introduction Decision-making process 201

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

MINISTRY OF HEALTH KENYA

Okinawa, Toyako, and Beyond: Progress on Health and Development

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

Bangladesh Resource Mobilization and Sustainability in the HNP Sector

TOWARDS UNIVERSAL ACCESS

Financing ART in low- and middleincome. Karl L. Dehne UNAIDS

INTERNAL QUESTIONS AND ANSWERS DRAFT

20 TH APRIL 2012 AT SILVER SPRING HOTEL NAIROBI

Draft resolution submitted by the President of the General Assembly

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

Harnessing the Cooperative Advantage to Build a Better World, Global Forum on Cooperatives, UNDESA, Addis Ababa, 4 6 September 2012,

Towards an AIDS Free Generation

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:

Please accept, Excellency, the assurances of our highest consideration.

ENVIROMENTAL AND SOCIAL HEALTH DETERMINANTS IN ZANZIBAR

Summary of PEPFAR State of Program Area (SOPA): Care & Support

HIV TESTING AND COUNSELING SERVICES IN THE WHO AFRICAN REGION. A Survey of the East and Southern Africa Subregion

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

OVERVIEW OF PAEDIATRIC SURGICAL ONCOLOGY SERVICES IN KENYA

Reintroducing the IUD in Kenya

The Sustainable Development Goals: The implications for health post Ties Boerma, Director of Information, Evidence and Research, WHO, Geneva

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

The road towards universal access

Linkages between Sexual and Reproductive Health and HIV

Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access -

The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT

HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE

Annex 13. Indicators for HIV testing services reference sheet

Successful results of clinical trials

MATERNAL AND CHILD SURVIVAL MEMORANDUM OF CONCERN

Elimination of motherto-child

THE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY

Integrating PMCT in RH / MCH services in Myanmar. 6 November 2006 At Kuala Lumpur

2003 Kenya Demographic and Health Survey (2003 KDHS) Youth in Kenya: Health and HIV

Botswana Private Sector Health Assessment Scope of Work

Assessment Schedule 2013 Health: Analyse an international health issue (91462)

UNINTENDED PREGNANCY BY THE NUMBERS

Transcription:

HIV TRENDS UNIVERSAL ACCESS TO HIV TREATMENT IN KENYA Dr Irene Mukui National AIDS & STD Control Programme 1

Outline Introduction HIV trends and current Statistics Access to ART Successes Challenges 2

Introduction HIV/AIDS remains a major challenge in Kenya. 50% reduction in prevalence over the past 10 years Kenya has mixed epidemic both generalized and concentrated Heterogeneity across age, sex and regions High HIV discordance within couples up to 45 % Low levels of HIV testing 3

HIV Prevalence by Province Western 5.4% Nyanza 14.9% Eastern 4.6% Rift Valley 6.3% North Eastern 0.8% Central 3.6% Great variation by geography ranging from 1% to 15% across provinces Nairobi 8.8% Kenya 7.1% Source KAIS 2007 Coast 8.1% 4

HIV Prevalence by Gender 7.1% (1.3 million) Kenyans age 15-64 were infected with HIV. % HIV Infected TOTAL FEMALES MALES 7.1 8.4 5.4 Source KAIS 2007 5

HIV Prevalence by Age & Gender HIV Prevalence (%) 14 12 10 8 6 4 2 0 Source KAIS 2007 3.5 1.0 7.4 1.9 10.2 7.3 13.3 8.9 11.2 Female to male ratio decreases with age. 9.3 9.4 10.2 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 Age Group 8.8 5.6 7.5 8.3 Male Female 4.7 2.3 3.4 1.7 6

HIV prevalence by Residence Rural: 6.7% Prevalence Urban: 8.4% Prevalence 1,027,000 persons infected 390,000 persons infected Source KAIS 2007 7

HIV trends in Kenya 12% 10.7% 10% HIV Prevalence (%) 8% 6% 4% 8.5% 8.7% 8.7% 8.5% 8.7% 7.9% 8.2% 6.9% 7.0% 7.3% 6.9% 6.2% 5.9% 4.9% 5.2% 4.9% 4.0% 3.7% 3.1% 2.6% 2.8% 9.0% 8.3% 7.7% 7.2% 7.0% 6.7% 6.1% 6.8% 5.7% 5.6% 5.1% 2% 1.5% 0% 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 Total (Actual HIV Prevalence of Pregnant Women) Total (Adjusted HIV Prevalence of Adult Population) Year 8

HIV prevalence by Province comparing KDHS & KAIS Source KAIS 2007 9

HIV trends 2003 and 2007 HIV prevalence among adults 15-49 years similar from 2003 (6.7%) to 2007 (7.4%). HIV prevalence in provinces in KDHS 2003 and KAIS 2007 similar,increase in North Eastern HIV prevalence remained high in urban populations, Increasing trend in rural populations in 2007 Significant changes by wealth index and education Populations with lower socioeconomic status have higher prevalence in 2007 than in 2003. 10 Source KAIS 2007

Universal Access to Treatment 11

Country Commitments ARVs in Kenyan private sector mid 1990 s Public sector program started in 2003 2006 provision of free ARVs for public sector through a presidential declaration Kenya part of WHO 3 by 5 initiative for treatment : target 95,000 on ART By end 2005 65,000 patients on ARVs in Kenya 12

Universal access Universal access implies that all people should be able to have access to information and services that are: Equitable accessible affordable comprehensive sustainable In 2006, countries worldwide including Kenya committed to setting ambitious national targets (UN General Assembly. Political Declaration on HIV/AIDS 2 June 2006) "Commit ourselves to setting ambitious national targets that reflect the commitment of the present Declaration and the urgent need to scale up significantly towards the goal of universal access to comprehensive prevention programmes, treatment, care and support by 2010" 13

ART providing sites by affiliation Percentage 80 GoK 70 Over 1000 service delivery points provide treatment 60 50 40 30 FBO 20 10 Private NGO CBO 0 GoK FBO Private NGO CBO 14

Scale up of ART Number 300000 250000 200000 150000 100000 50000 0 June 20004 2004 2005 2006 2007 2008 Jun-09 Adult Paediatric 15

Universal access? 12% of HIV-infected adults were taking Cotrimoxazole daily to prevent infections Overall, 40% of ARV-eligible adults were taking ARVs. Among those who knew they were infected with HIV, 76% were taking Cotrimoxazole daily 92% of ARV-eligible adults were taking ARVs. Data suggests high access to care and treatment for those aware of HIV status KAIS 2007 16

2008/2009 Universal access? 520,000 persons in need of ARVs 55 % on ARVs ( 290,000 ) total 50 % of children on ARVs Eligible population increases annually ( projections) 780,000 persons have been enrolled into care at a point 17

Successes Rapid scale up treatment in past 6 years HIV contributed to health systems strengthening Infrastructure Personnel Funding High access to care and treatment for those aware of HIV status 18

Health systems Challenges Burden to health care system and weak health systems increasing number of outpatient visits, strain on Human resources Limited infrastructure (space, laboratory) drug procurement and supply management systems System unprepared for chronic care Inequality of service distribution.majority concentrated in urban centres 19

Challenges Sustainability of funding for HIV programmes predictable and sustainable financing Challenges posed by decentralization of care to lower cadres and lower levels vs. quality of care Stigma and discrimination Weak monitoring systems Treatment outcomes Quality of care Retention of patients on treatment, follow up systems Low knowledge of HIV status limits access to treatment 20

Emerging Issues HIV treatment for prevention Treat all vs. increase in CD4 cut offs for initiation of treatment Shift to use of less toxic regimens Health systems strengthening Sustainable financing, increasing Government financing for HIV 21